Chunxia Ji

958# Jinguang Road
Shanghai, 200000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Convection-Enhanced Delivery of Tumor-Infiltrating Lymphocytes Enhances Intratumoral Distribution and Therapeutic Efficacy in an Orthotopic Rat Glioma Model.

Convection-Enhanced Delivery of Tumor-Infiltrating Lymphocytes Enhances Intratumoral Distribution and Therapeutic Efficacy in an Orthotopic Rat Glioma Model.

Journal: Biomedicines

Published: February 25, 2026

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical Trial.

Journal: Clinical Medicine Insights. Oncology

Published: February 07, 2025

Using MRI to Determine Drug Concentration in Convection-Enhanced Delivery: A Proof-of-Concept study.

Using MRI to Determine Drug Concentration in Convection-Enhanced Delivery: A Proof-of-Concept study.

Journal: Neuroscience letters

Published: September 10, 2024

MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma.

MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma.

Journal: Biomarker research

Published: October 29, 2023

Integration of 3D bioprinting and multi-algorithm machine learning identified glioma susceptibilities and microenvironment characteristics.

Integration of 3D bioprinting and multi-algorithm machine learning identified glioma susceptibilities and microenvironment characteristics.

Journal: Cell discovery

Published: June 27, 2023

The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside.

The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside.

Journal: Translational oncology

Published: June 17, 2023

Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.

Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma.

Journal: Journal of neuro-oncology

Published: May 25, 2023

B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas.

B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas.

Journal: Neoplasia (New York, N.Y.)

Published: April 11, 2023

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma.

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma.

Journal: Brain sciences

Published: January 05, 2022

Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.

Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.

Journal: Journal for immunotherapy of cancer

Published: March 24, 2020

Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC

Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: August 28, 2019

Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.

Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.

Journal: Neuro-oncology

Published: July 06, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026